Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fenfluramine: long-term reduction in brain serotonin (5-hydroxytryptamine).

B V Clineschmidt, J A Totaro, J C McGuffin

    European Journal of Pharmacology
    |January 1, 1976
    PubMed
    Summary

    Fenfluramine significantly reduces brain serotonin levels in rats, with effects lasting for weeks after a single dose. Multiple doses further deplete serotonin, indicating a long-lasting impact on serotonin neurons.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist.

    Life sciences·1996
    Same author

    1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.

    Journal of medicinal chemistry·1995
    Same author

    Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation.

    Bioorganic & medicinal chemistry·1994
    Same author

    1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.

    Journal of medicinal chemistry·1994
    Same author

    Development and pharmacological assessment of novel peptide and nonpeptide oxytocin antagonists.

    Regulatory peptides·1993
    Same author

    Identification of an orally active, nonpeptidyl oxytocin antagonist.

    The Journal of pharmacology and experimental therapeutics·1993

    Area of Science:

    • Neuropharmacology
    • Neurochemistry

    Background:

    • Serotonin is a key neurotransmitter involved in various brain functions.
    • Understanding the long-term effects of drugs on neurotransmitter systems is crucial for assessing their safety and efficacy.

    Purpose of the Study:

    • To investigate the duration and cumulative effects of fenfluramine on brain serotonin levels in a rat model.

    Main Methods:

    • Rats were administered single or multiple oral doses of fenfluramine (15 mg/kg, 3 mg/kg, or 5 mg/kg).
    • Brain serotonin concentrations were measured at various time points post-administration (1, 15, and 30 days).

    Main Results:

    • A single 15 mg/kg dose of fenfluramine reduced brain serotonin to 48-63% of control levels up to 30 days.

    Related Experiment Videos

  • Lower doses (3 mg/kg) also caused significant, cumulative serotonin depletion with repeated administration.
  • Even after 14 days post-treatment, brains from rats receiving 5 mg/kg daily showed 60% of control serotonin levels.

    • Conclusions:

    • Fenfluramine exerts a prolonged and dose-dependent reduction in brain serotonin.
    • The drug's action on serotonin-containing neurons is long-lasting, with potential for cumulative effects.